Wuhan Pulmonary Hospital

This study is testing whether a new 6-month, all-oral combination of four drugs is as effective and safe as the standard, much longer treatment for drug-resistant tuberculosis (TB). It will involve 52 adults in Hubei Province, China, who have this hard-to-treat form of TB. The go…

This study aims to see if a newer, shorter 6-month oral treatment works as well and is as safe for people with both drug-resistant tuberculosis (TB) and type 2 diabetes, compared to people with TB alone. It will enroll 60 participants aged 12 and older. Researchers will compare t…